Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
Table 2
Characteristics of pregnant women with chronic hepatitis B virus infection in 2011 by prescription of antiviral treatment.
Pregnant women ()
Nonpregnant women ()
Antiviral treatment
No antiviral treatment
Antiviral treatment
No antiviral treatment
()
()
()
()
Mean age (range)
33.4 (22–46) years
32.9 (14–48) years
38.8 (10–50) years
37.2 (10–50) years
%
%
%
%
Metropolitan
Yes
62
96.9
430
97.1
1115
96.9
4484
97.1
No
2
3.1
12
2.7
36
3.1
132
2.9
Region
Northeast
15
23.4
101
22.8
225
19.5
1063
23.0
North Central
10
15.6
77
17.4
129
11.2
596
12.9
South
14
21.9
99
22.3
362
31.5
1163
25.2
West
25
39.1
156
35.2
426
37.0
1722
37.3
HIV coinfection
Yes
0
0
5
1.1
5
0.4
74
1.6
No
64
100.0
438
98.9
1146
99.6
4542
98.4
The differences between nonpregnant women with and without antiviral treatment were statistically significant for age, region, and HIV status at . Percentages were of total subjects: due to missing or invalid data, the sum of some subcategories and their associated percentages do not equal 100.
